BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 1247 | Download: 1335
 |
Received |
|
2014-06-25 09:11 |
 |
Peer-Review Started |
|
2014-06-27 08:43 |
 |
To Make the First Decision |
|
2014-09-16 11:01 |
 |
Return for Revision |
|
2014-09-16 15:03 |
 |
Revised |
|
2014-09-22 00:00 |
 |
Second Decision |
|
2014-10-10 18:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-10-10 18:13 |
 |
Articles in Press |
|
2014-10-10 18:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-28 17:52 |
 |
Publish the Manuscript Online |
|
2014-12-12 11:14 |
Category |
Transplantation |
Manuscript Type |
Therapeutics Advances |
Article Title |
Perspective of antiviral therapeutics for hepatitis C after liver transplantation
|
Manuscript Source |
Invited Manuscript |
All Author List |
Cheng-Maw Ho, Rey-Heng Hu and Po-Huang Lee |
Funding Agency and Grant Number |
|
Corresponding Author |
Cheng-Maw Ho, MD, Department of Surgery, National Taiwan University Hospital, 7 Chun-Shan S Rd, Taipei 100, Taiwan. miningho@ntu.edu.tw |
Key Words |
Hepatitis C; Recurrence; Liver transplantation; Therapeutics; Fibrosis |
Core Tip |
Management of hepatitis C virus (HCV) recurrence after liver transplantation used to be a bothering issue due mostly to the interferon-based therapy. Current available data from treatment of chronic HCV infection shows promising results of interferon-free, or even ribavirin-free, pan-genotypic, all oral medications will soon reform the treatment of HCV recurrence after liver transplantation. |
Publish Date |
2014-12-12 11:14 |
Citation |
Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198 |
URL |
http://www.wjgnet.com/2220-3192/full/v3/i4/193.htm |
DOI |
http://dx.doi.org/10.5497/wjp.v3.i4.193 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345